Home
Live Updates
Antengene To Present One Oral and Four Abstracts at ASCO 2024 : comparemela.com
Antengene To Present One Oral and Four Abstracts at ASCO 2024
/PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated...
Related Keywords
China ,
Chicago ,
Illinois ,
United States ,
Shanghai ,
Taiwan ,
Macau ,
South Korea ,
Hong Kong ,
Singapore ,
Australia ,
Beijing ,
Mccormick Place ,
American ,
Asia Pacific ,
Peter Qian ,
Antengene Corporation Limited ,
Prnewswire Antengene Corporation Limited ,
Mccormick Place Convention Center ,
Hong Kong Stock Exchange ,
Company Annual ,
Antengene Corporation ,
American Society Of Clinical Oncology ,
Oral Presentation ,
Corporation Limited ,
Clinical Oncology ,
Annual Meeting ,
Clinical Science Symposium ,
Stronger Together ,
Novel Combinations Across ,
Gynecologic Cancer ,
Central Daylight Time ,
Beijing Time ,
Poster Presentations ,
Developmental Therapeutics ,
Bayesian Optimal Interval ,
Molecularly Targeted Agents ,
Hematologic Malignancies ,
Chronic Lymphocytic ,
Journal Publication ,
Publication Only ,
Patients Beyond ,
Taiwan China ,
Hong Kong China ,
Macau China ,
Annual Report ,
Hong Kong Stock ,
comparemela.com © 2020. All Rights Reserved.